We are live on ! Find out more
ATOS icon

Atossa Therapeutics
ATOS

49 hedge funds and large institutions have $14.2M invested in Atossa Therapeutics in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 18 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,509% more call options, than puts

Call options by funds: $1.06M | Put options by funds: $66K

19% more capital invested

Capital invested by funds: $11.9M → $14.2M (+$2.29M)

0% less ownership

Funds ownership: 0.86% → 0.86% (-0%)

9% less funds holding

Funds holding: 54 → 49 (-5)

56% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 18

63% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 8

Holders
49
Holders Change
-5
Holders Change %
-9.26%
% of All Funds
0.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
8
Reduced
18
Closed
8
Calls
$1.06M
Puts
$66K
Net Calls
+$996K
Net Calls Change
+$299K

Top Buyers

Rank Fund Capital Flow
1
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$254K
2
GCP
GSA Capital Partners
United Kingdom
+$73.1K
3
Morgan Stanley
Morgan Stanley
New York
+$57.4K
4
Squarepoint
Squarepoint
New York
+$45.4K
5
Renaissance Technologies
Renaissance Technologies
New York
+$30.1K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$138K
2
BlackRock
BlackRock
New York
-$64.8K
3
XT
XTX Topco
Cayman Islands
-$59K
4
VF
Virtu Financial
New York
-$59K
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$42.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
LCM
26
LVM Capital Management
Michigan
$18K – – –
Osaic Holdings
27
Osaic Holdings
Arizona
$10.2K -$1.57K -146 -16%
JLBC
28
J.L. Bainbridge & Co
Florida
$9.79K – – –
RJFSA
29
Raymond James Financial Services Advisors
Florida
$9.52K -$874 -81 -10%
TRCT
30
Tower Research Capital (TRC)
New York
$9.46K -$1.78K -165 -19%
FDCDDQ
31
Federation des caisses Desjardins du Quebec
Quebec, Canada
$9.33K -$1.44K -133 -16%
AWS
32
Atria Wealth Solutions
New York
$8.8K – – –
Citadel Advisors
33
Citadel Advisors
Florida
$8.04K -$25.9K -2,401 -80%
BNP Paribas Financial Markets
34
BNP Paribas Financial Markets
France
$4.01K – – –
Fidelity Investments
35
Fidelity Investments
Massachusetts
$3.66K -$11 -1 -0.4%
Bank of America
36
Bank of America
North Carolina
$1.86K +$119 +11 +8%
HI
37
Harbour Investments
Wisconsin
$1.51K – – –
SJIM
38
St. Johns Investment Management
Florida
$1.36K – – –
Wells Fargo
39
Wells Fargo
California
$801 +$32 +3 +5%
TWC
40
TD Waterhouse Canada
Ontario, Canada
$637 – – –
AF
41
Allworth Financial
California
$618 – – –
CP
42
Castleview Partners
Texas
$440 – – –
DWA
43
Delos Wealth Advisors
Texas
$88 – – –
JP Morgan Chase
44
JP Morgan Chase
New York
$83 – – –
CA
45
Clearstead Advisors
Ohio
$62 -$43 -4 -44%
Qube Research & Technologies (QRT)
46
Qube Research & Technologies (QRT)
United Kingdom
$48 – – –
UBS Group
47
UBS Group
Switzerland
$26 -$24K -2,222 -100%
VF
48
Virtu Financial
New York
– -$59K -5,382 Closed
TSS
49
Two Sigma Securities
New York
– -$26.9K -2,431 Closed
HF
50
HRT Financial
New York
– -$21K -1,943 Closed
1
2
3

ATOS Hedge Fund Activity: Q4 2023 in Review

49 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Atossa Therapeutics (ATOS) for Q4 2023, worth a combined $14.2M — up 19% from $11.9M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of ATOS and 3 opened new positions — a net loss of 5 holders — while 18 trimmed existing stakes and 8 added.

The largest buyer was Bank of Montreal, opening a new position worth an estimated $254K. The largest seller was Millennium Management, cutting an estimated $138K.

  • 49 institutional investors held Atossa Therapeutics (ATOS) as of Q4 2023, down from 54 in Q3 2023.
  • Funds reported $14.2M of Atossa Therapeutics stock for Q4 2023, up 19% quarter-over-quarter.
  • 3 funds opened new Atossa Therapeutics positions in Q4 2023 and 8 closed out, a net change of -5 holders.
  • The largest Atossa Therapeutics buyer in Q4 2023 was Bank of Montreal, an estimated $254K added.
  • The largest Atossa Therapeutics seller in Q4 2023 was Millennium Management, an estimated $138K sold.

Based on aggregated 13F filings for Q4 2023.